Identification of novel PI3Kα inhibitors for colon cancer treatment via virtual screening, molecular dynamics simulation, and in vitro activity validation

Molecular Diversity 2026

View at publisher

Authors: Yu-Chen Wang, Xue Su, X Chen, Xiu‐Yun Shi, Zhoulan Bai, Hui Zhang

DOI: 10.1007/s11030-025-11462-6

Cited by: 0

References: 32

Fields of Study & Subjects

Computational Drug Discovery Methods PI3K/AKT/mTOR signaling in cancer Synthesis and Characterization of Heterocyclic Compounds

References 32